Guidance on the use of bisphosphonates in solid tumours : recommendations of an international expert panelAAPRO, M; ABRAHAMSSON, P. A; HADJI, P et al.Annals of oncology. 2008, Vol 19, Num 3, pp 420-432, issn 0923-7534, 13 p.Article

Effect of food on the pharmacokinetics of capecitabine and its metabolites following oral administration in cancer patientsREIGNER, B; VERWEIJ, J; OSTERWALDER, B et al.Clinical cancer research. 1998, Vol 4, Num 4, pp 941-948, issn 1078-0432Article

Neoadjuvant and adjuvant therapy for invasive bladder tumoursDIRIX, L. Y; VAN OOSTEROM, A. T.European journal of cancer (1990). 1991, Vol 27, Num 3, pp 326-330, issn 0959-8049Conference Paper

Safety and efficacy of neratinib (HKI-272) plus vinorelbine in the treatment of patients with ErbB2-positive metastatic breast cancer pretreated with anti-HER2 therapyAWADA, A; DIRIX, L; MANSO SANCHEZ, L et al.Annals of oncology. 2013, Vol 24, Num 1, pp 109-116, issn 0923-7534, 8 p.Article

Delivery of adjuvant sequential dose-dense FEC-Doc to patients with breast cancer is feasible, but dose reductions and toxicity are dependent on treatment sequenceWILDIERS, H; DIRIX, L; NEVEN, P et al.Breast cancer research and treatment. 2009, Vol 114, Num 1, pp 103-112, issn 0167-6806, 10 p.Article

A randomised phase II study of two different schedules of pegylated liposomal doxorubicin in metastatic breast cancer (EORTC-10993)COLEMAN, R. E; BIGANZOLI, L; CANNEY, P et al.European journal of cancer (1990). 2006, Vol 42, Num 7, pp 882-887, issn 0959-8049, 6 p.Article

The effect of exemestane on serum lipid profile in postmenopausal women with metastatic breast cancer: a companion study to EORTC Trial 10951, 'Randomized phase II study in first line hormonal treatment for metastatic breast cancer with exemestane or tamoxifen in postmenopausal patients'ATALAY, G; DIRIX, L; PICCART, M et al.Annals of oncology. 2004, Vol 15, Num 2, pp 211-217, issn 0923-7534, 7 p.Article

A randomized, double-blind, multicenter, phase 2 study of a human monoclonal antibody to human αv integrins (intetumumab) in combination with docetaxel and prednisone for the first-line treatment of patients with metastatic castration-resistant prostate cancerHEIDENREICHL, A; RAWAL, S. K; SCHRIJVERS, D et al.Annals of oncology. 2013, Vol 24, Num 2, pp 329-336, issn 0923-7534, 8 p.Article

Distinct molecular phenotype of inflammatory breast cancer compared to non-inflammatory breast cancer using Affymetrix-based genome-wide gene-expression analysisVAN LAERE, S; VAN DER AUWERA, I; VAN DEN EYNDEN, G et al.British journal of cancer. 2007, Vol 97, Num 8, pp 1165-1174, issn 0007-0920, 10 p.Article

Circulating basic fibroblast growth factor is partly derived from the tumour in patients with colon, cervical and ovarian cancerSALGADO, R; BENOY, I; VERMEULEN, P et al.Angiogenesis (London). 2004, Vol 7, Num 1, pp 29-32, issn 0969-6970, 4 p.Article

A phase II trial of ZD0473 in platinum-pretreated ovarian cancerGORE, M. E; ATKINSON, R. J; THOMAS, H et al.European journal of cancer (1990). 2002, Vol 38, Num 18, pp 2416-2420, issn 0959-8049, 5 p.Article

A phase I study of capecitabine in combination with oral leucovorin in patients with intractable solid tumorsCASSIDY, J; DIRIX, L; BISSETT, D et al.Clinical cancer research. 1998, Vol 4, Num 11, pp 2755-2761, issn 1078-0432Article

Capecitabine, an oral fluoropyrimidine carbamate with substantial activity in advanced colorectal cancer : Results of a randomized phase II studyVAN CUTSEM, E; FINDLAY, M; SEITZ, J.-F et al.Journal of clinical oncology. 2000, Vol 18, Num 6, pp 1337-1345, issn 0732-183XArticle

Effects of suramin on anastomotic colon tumors in a rat modelLAUWERS, P; HUBENS, G; EYSKENS, E et al.European surgical research. 1999, Vol 31, Num 4, pp 347-356, issn 0014-312XArticle

A phase II study of irinotecan alternated with five days bolus of 5-fluorouracil and leucovorin in first-line chemotherapy of metastatic colorectal cancerVAN CUTSEM, E; POZZO, C; COTE, C et al.Annals of oncology. 1998, Vol 9, Num 11, pp 1199-1204, issn 0923-7534Article

Quantification and prognostic relevance of angiogenic parameters in invasive cervical cancerTJALMA, W; VAN MARCK, E; WEYLER, J et al.British journal of cancer. 1998, Vol 78, Num 2, pp 170-174, issn 0007-0920Conference Paper

Phase I and pharmacokinetic study of KW-2149 given by 24 hours continuous infusionDIRIX, L; CATIMEL, G; VERDONK, R et al.Investigational new drugs. 1995, Vol 13, Num 2, pp 133-136, issn 0167-6997Article

Prehospital thrombolytic treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complexBOSSAERT, L. L; DEMEY, H. E; COLEMONT, L. J et al.Critical care medicine. 1988, Vol 16, Num 9, pp 823-830, issn 0090-3493Article

Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancerFALANDRY, C; CANNEY, P. A; FREYER, G et al.Annals of oncology. 2009, Vol 20, Num 4, pp 615-620, issn 0923-7534, 6 p.Article

The management of ovarian cancerPROVE, A. M; DIRIX, L. Y; SCHRIJVERS, D et al.Annals of oncology. 1993, Vol 4, Num 10, pp 883-887, issn 0923-7534Article

Correlation of the fractions of proliferating tumor and endothelial cells in breast and colorectal adenocarcinoma is independent of tumor histiotype and microvessel densityVERMEULEN, P. B; DIRIX, L. Y; LIBURA, J et al.Microvascular research (Print). 1997, Vol 54, Num 1, pp 88-92, issn 0026-2862Article

Serum basic fibroblast growth factor and vascular endothelial growth factor and tumour growth kinetics in advanced colorectal cancerDIRIX, L. Y; VERMEULEN, P. B; HUBENS, G et al.Annals of oncology. 1996, Vol 7, Num 8, pp 843-848, issn 0923-7534Article

Compassionate use of tropisetron in patients at high risk of severe emesisBLEIBERG, H; VAN BELLE, S; PARIDAENS, R et al.Annals of oncology. 1993, Vol 4, pp S43-S45, issn 0923-7534, SUP3Conference Paper

Granulocyte-macrophage colony stimulating factor (GM-CSF) after high-dose melphalan in patients with advanced colon cancerSTEWARD, W. P; SCARFFE, J. H; DIRIX, L. Y et al.British journal of cancer. 1990, Vol 61, Num 5, pp 749-754, issn 0007-0920, 6 p.Article

Correlation of intratumoral microvessel density and p53 protein overexpression in human colorectal adenocarcinomaVERMEULEN, P. B; ROLAND, L; MERTENS, V et al.Microvascular research (Print). 1996, Vol 51, Num 2, pp 164-174, issn 0026-2862Article